Biotech

All Articles

Relay loses interest in SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech device bowed out an SHP2 inhibitor deal, Relay Therapy has affi...

Stoke's Dravet disorder med released of partial clinical grip

.Stoke Rehabs' Dravet syndrome drug has actually been devoid of a partial hold, removing the method ...

Fierce Biotech's Gabrielle Masson presents Intense 15 at NYSE

.Strong Biotech Affiliate Editor Gabrielle Masson presented the 2024 training class of Strong 15 cha...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) a...

Daiichi pays for Merck $170M to form lung cancer cells T-cell engager contract

.Merck &amp Co. has actually promptly recouped several of the prices of its Harp on Therapies buyout...

BioMarin standstills preclinical gene treatment for heart condition

.After BioMarin conducted a springtime clean of its own pipe in April, the company has decided that ...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks deal

.Major Pharmas stay stuck to the tip of molecular adhesive degraders. The most up to date firm to vi...

Life science credit scores company introduces along with $600M

.A brand new global lifestyle science debt agency, called Symbiotic Funding, has brought up greater ...

BMS ditches TIGIT, ignoring $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing another significant wager coming from the Caforio time, canc...

Nuvation stops BET prevention after considering stage 1 record

.After taking a look at phase 1 data, Nuvation Bio has actually made a decision to halt focus on its...